{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T04:30:10Z","timestamp":1786336210713,"version":"build-2736575974"},"reference-count":38,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Research, Development and Innovation Fund of the Ministry for Innovation and Technology","award":["TKP2021-NKTA-42"],"award-info":[{"award-number":["TKP2021-NKTA-42"]}]},{"name":"National Research, Development and Innovation Fund of the Ministry for Innovation and Technology","award":["151414"],"award-info":[{"award-number":["151414"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background\/Objectives: Palladium-103 (103Pd) is an Auger electron-emitting radionuclide with nanometer-scale penetration ranges that result in highly localized energy deposition, making it well suited for molecularly targeted radionuclide therapy. However, efficient production, separation, and in vivo evaluation workflows remain limited. This study aimed to establish a scalable workflow for the production, separation, purification, radiolabeling, and preclinical assessment of 103Pd for theranostic applications. Methods:\u00a0103Pd was produced via the 103Rh(p,n)103Pd reaction. An upgraded dry-distillation radionuclide separation equipment (RSE) enabled high-efficiency separation from irradiated rhodium foils, while a cotton-assisted acid recovery process yielded purified 103Pd suitable for radiolabeling. Chelation with NOTA and DOTA-TATE was performed, and radiochemical purity was assessed using iTLC, SPE, and a C18 column. In vivo SPECT\/CT imaging was conducted in NMRI Nu\/Nu mice and in a canine model with spontaneous liver metastatic spread of insulinoma, injected with [103Pd]Pd-labeled compounds. Results: The upgraded RSE achieved separation efficiencies of 64\u201386% and overall recovery yields of 81\u201394%, outperforming conventional wet-chemistry methods. Radiolabeling produced stable complexes with &gt;95% radiochemical purity. SPECT\/CT imaging confirmed in vivo stability in mice. In the canine model, a slight reduction in tumor size and increased glucose levels were observed during 24 days post-systemic application of 520 MBq of 103Pd-DOTA-TATE radioactivity. Conclusions: This study establishes a complete and efficient radiochemical and preclinical pipeline for 103Pd, demonstrating its feasibility as a theranostic radionuclide. The combination of high-yield production, robust separation chemistry, and localized Auger-mediated energy deposition highlights 103Pd as a promising candidate for future targeted radionuclide therapy applications.<\/jats:p>","DOI":"10.3390\/ph19081140","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:05:42Z","timestamp":1784819142000},"page":"1140","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Palladium-103 as a Theranostic Auger Electron Emitter: From Cyclotron Production to Preclinical SPECT Evaluation in Murine and Canine Models"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2799-0078","authenticated-orcid":false,"given":"Aicha Nour","family":"Laouameria","sequence":"first","affiliation":[{"name":"Doctoral School of Chemistry, University of Debrecen, Egyetem t\u00e9r 1, 4032 Debrecen, Hungary"},{"name":"HUN-REN Institute for Nuclear Research, Bem t\u00e9r 18\/c, 4026 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6727-1725","authenticated-orcid":false,"given":"Domokos","family":"M\u00e1th\u00e9","sequence":"additional","affiliation":[{"name":"Department of Biophysics and Radiation Biology, HUN-REN TKI, Semmelweis University, 1094 Budapest, Hungary"},{"name":"In Vivo Imaging Advanced Core Facility, Hungarian Centre of Excellence for Molecular Medicine, 1094 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anik\u00f3","family":"Kubovje","sequence":"additional","affiliation":[{"name":"Department of Biophysics and Radiation Biology, HUN-REN TKI, Semmelweis University, 1094 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Vajdovich","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology and Oncology, University of Veterinary Medicine, 1078 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2742-173X","authenticated-orcid":false,"given":"Gyula","family":"Balka","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Veterinary Medicine, 1078 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ty\u00e1s","family":"Hunyadi","sequence":"additional","affiliation":[{"name":"HUN-REN Institute for Nuclear Research, Bem t\u00e9r 18\/c, 4026 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8733-4286","authenticated-orcid":false,"given":"Ralf K.","family":"Bergmann","sequence":"additional","affiliation":[{"name":"Department of Biophysics and Radiation Biology, HUN-REN TKI, Semmelweis University, 1094 Budapest, Hungary"},{"name":"In Vivo Imaging Advanced Core Facility, Hungarian Centre of Excellence for Molecular Medicine, 1094 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"Halldin","sequence":"additional","affiliation":[{"name":"Department of Biophysics and Radiation Biology, HUN-REN TKI, Semmelweis University, 1094 Budapest, Hungary"},{"name":"Department of Clinical Neuroscience, Karolinska Institute, 171 77 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6089-9124","authenticated-orcid":false,"given":"L\u00e1szl\u00f3","family":"Forg\u00e1ch","sequence":"additional","affiliation":[{"name":"Department of Biophysics and Radiation Biology, HUN-REN TKI, Semmelweis University, 1094 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9390-7925","authenticated-orcid":false,"given":"Ildik\u00f3","family":"Horv\u00e1th","sequence":"additional","affiliation":[{"name":"Department of Biophysics and Radiation Biology, HUN-REN TKI, Semmelweis University, 1094 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0828-9828","authenticated-orcid":false,"given":"Kriszti\u00e1n","family":"Szigeti","sequence":"additional","affiliation":[{"name":"Department of Biophysics and Radiation Biology, HUN-REN TKI, Semmelweis University, 1094 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Ps\u00e1der","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Veterinary Medicine, 1078 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0794-3012","authenticated-orcid":false,"given":"Jan Rijn","family":"Zeevaart","sequence":"additional","affiliation":[{"name":"NuMeRI, Nuclear Medicine Research Infrastructure NPC, Steve Biko Academic Hospital, Pretoria 0084, South Africa"},{"name":"Applied Radiation, South African Nuclear Energy Corporation (Necsa), Pelindaba 0240, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00f3r\u00e1nt","family":"Csige","sequence":"additional","affiliation":[{"name":"HUN-REN Institute for Nuclear Research, Bem t\u00e9r 18\/c, 4026 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0581-2975","authenticated-orcid":false,"given":"Zolt\u00e1n","family":"Sz\u0171cs","sequence":"additional","affiliation":[{"name":"HUN-REN Institute for Nuclear Research, Bem t\u00e9r 18\/c, 4026 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Gudkov, S.V., Shilyagina, N.Y., Vodeneev, V.A., and Zvyagin, A.V. (2015). Targeted radionuclide therapy of human tumors. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17010033"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e257772","DOI":"10.1136\/bcr-2023-257772","article-title":"Diffuse pneumonitis after Lutetium-177-PSMA-617 treatment in a patient with metastatic castration-resistant prostate cancer","volume":"17","author":"Wang","year":"2024","journal-title":"BMJ Case Rep. CP"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s13277-011-0286-y","article-title":"An overview of targeted alpha therapy","volume":"33","author":"Kim","year":"2012","journal-title":"Tumor Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"035016","DOI":"10.1088\/1361-6560\/abd3ef","article-title":"Effect of microdistribution of alpha and beta-emitters in targeted radionuclide therapies on delivered absorbed dose in a GATE model of bone marrow","volume":"66","author":"Tranel","year":"2021","journal-title":"Phys. Med. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1088\/0031-9155\/41\/10\/009","article-title":"Targeted radiotherapy using Auger electron emitters","volume":"41","author":"Wheldon","year":"1996","journal-title":"Phys. Med. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.nucmedbio.2021.03.002","article-title":"Auger: The future of precision medicine","volume":"96","author":"Pirovano","year":"2021","journal-title":"Nucl. Med. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2967\/jnumed.114.153502","article-title":"Monte Carlo evaluation of Auger electron\u2013emitting theranostic radionuclides","volume":"56","author":"Falzone","year":"2015","journal-title":"J. Nucl. Med."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Reissig, F., Mamat, C., Steinbach, J., Pietzsch, H.-J., Freudenberg, R., Navarro-Retamal, C., Caballero, J., Kotzerke, J., and Wunderlich, G. (2016). Direct and Auger electron-induced, single-and double-strand breaks on plasmid DNA caused by 99mTc-labeled pyrene derivatives and the effect of bonding distance. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0161973"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s41181-019-0075-2","article-title":"Auger electrons for cancer therapy\u2014A review","volume":"4","author":"Ku","year":"2019","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/rpd\/ncs132","article-title":"Monte Carlo mitochondrial dosimetry and microdosimetry of 131I","volume":"153","year":"2013","journal-title":"Radiat. Prot. Dosim."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.apradiso.2018.08.019","article-title":"Micro-dosimetry calculation of Auger-electron-emitting radionuclides mostly used in nuclear medicine using GEANT4-DNA","volume":"141","author":"Moradi","year":"2018","journal-title":"Appl. Radiat. Isot."},{"key":"ref_12","unstructured":"Fourie, H. (2014). Microdosimetric Studies of Auger Electrons from DNA-Incorporated 123-I Using the Micronucleus Assay and the Geant4 Monte Carlo Simulation Tookit. [Doctoral Dissertation, Stellenbosch University]."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1367-5931(99)80014-3","article-title":"How does radiation kill cells?","volume":"3","author":"Bernhard","year":"1999","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.7150\/thno.95436","article-title":"Palladium-103 (103Pd\/103mRh), a promising auger-electron emitter for targeted radionuclide therapy of disseminated tumor cells-absorbed doses in single cells and clusters, with comparison to 177Lu and 161Tb","volume":"14","author":"Larouze","year":"2024","journal-title":"Theranostics"},{"key":"ref_15","unstructured":"International Atomic Energy Agency (2019). Live Chart of Nuclides Nuclear Structure and Decay Data, International Atomic Energy Agency."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Laouameria, A.N., Driver, C.H., Buys, M., Kurakina, E.S., Hunyadi, M., Zeevaart, J.R., and Szucs, Z. (2026). Evaluation of Daughter Radionuclide Release from the 103Pd\/103mRh In Vivo Generator for Targeted Auger Therapy. Pharmaceuticals, 19.","DOI":"10.3390\/ph19010126"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0969-8043(02)00054-4","article-title":"Measurements and nuclear model calculations on proton-induced reactions on 103Rh up to 40 MeV: Evaluation of the excitation function of the 103Rh (p, n) 103Pd reaction relevant to the production of the therapeutic radionuclide 103Pd","volume":"56","author":"Qaim","year":"2002","journal-title":"Appl. Radiat. Isot."},{"key":"ref_18","unstructured":"(2009). Cyclotron Produced Radionuclides-Physical Characteristics and Production Methods, International Atomic Energy Agency."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.hydromet.2014.12.006","article-title":"Recovery of platinum, palladium and rhodium from acidic chloride leach solution using ion exchange resins","volume":"152","author":"Nikoloski","year":"2015","journal-title":"Hydrometallurgy"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Laouameria, A.N., Hunyadi, M., Cs\u00edk, A., and Sz\u0171cs, Z. (2024). Innovative Approach to Producing Palladium-103 for Auger-Emitting Radionuclide Therapy: A Proof-of-Concept Study. Pharmaceuticals, 17.","DOI":"10.20944\/preprints202401.0519.v1"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0360-3016(99)00499-X","article-title":"Palladium-103 brachytherapy for prostate carcinoma","volume":"46","author":"Blasko","year":"2000","journal-title":"Int. J. Radiat. Oncol.*Biol.*Phys."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1148\/92.7.1453","article-title":"Radioactive albumin microspheres for studies of the pulmonary circulation","volume":"92","author":"Rhodes","year":"1969","journal-title":"Radiology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0020-708X(70)90006-2","article-title":"Preparation of metabolizable radioactive human serum albumin microspheres for studies of the circulation","volume":"21","author":"Zolle","year":"1970","journal-title":"Int. J. Appl. Radiat. Isot."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Jiang, X., Chen, L., and Xu, X. (2025). Advancements in the investigation of radioactive microspheres for brachytherapy. Front. Bioeng. Biotechnol., 13.","DOI":"10.3389\/fbioe.2025.1621418"},{"key":"ref_25","unstructured":"Hermanson, G.T. (2013). Bioconjugate Techniques, Academic Press."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Chandekar, K.R., and Bal, C. (2025). Advances with 225Ac-DOTATATE Targeted Alpha Therapy in Somatostatin Receptor Positive Neuroendocrine Tumors. Proceedings of the Seminars in Nuclear Medicine, Elsevier.","DOI":"10.1053\/j.semnuclmed.2025.06.008"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1109\/TRPMS.2022.3201757","article-title":"Simultaneous imaging of Ga-DOTA-TATE and Lu-DOTA-TATE in murine models of neuroblastoma","volume":"7","author":"Zheng","year":"2022","journal-title":"IEEE Trans. Radiat. Plasma Med. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s10967-022-08189-1","article-title":"Upgrade of recommended nuclear cross section data base for production of therapeutic radionuclides","volume":"331","author":"Hermanne","year":"2022","journal-title":"J. Radioanal. Nucl. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kim, H.-C., and Kim, G.M. (2023). Radiation pneumonitis following Yttrium-90 radioembolization: A Korean multicenter study. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.977160"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/09553000400017663","article-title":"The amazing world of auger electrons","volume":"80","author":"Kassis","year":"2004","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"214343","DOI":"10.1016\/j.ccr.2021.214343","article-title":"Palladium (II) coordination with polyazacycloalkanes","volume":"455","author":"Pineau","year":"2022","journal-title":"Coord. Chem. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e202200942","DOI":"10.1002\/chem.202200942","article-title":"Relevance of palladium to radiopharmaceutical development considering enhanced coordination properties of TE1PA","volume":"28","author":"Pineau","year":"2022","journal-title":"Chem.\u2014Eur. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"11884","DOI":"10.1021\/acs.inorgchem.4c01780","article-title":"Relevance of Oxocyclam from Palladium (II) Coordination to Radiopharmaceutical Development","volume":"63","author":"Hojorat","year":"2024","journal-title":"Inorg. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Qaim, S. (2011). Cyclotron production of medical radionuclides. Handbook of Nuclear Chemistry, Springer.","DOI":"10.1007\/978-1-4419-0720-2_39"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.anucene.2011.06.018","article-title":"Investigation of palladium-103 production and IR07-103Pd brachytherapy seed preparation","volume":"38","author":"Saidi","year":"2011","journal-title":"Ann. Nucl. Energy"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.nucmedbio.2007.10.008","article-title":"Yttrium-86-labelled human serum albumin microspheres: Relation of surface structure with in vivo stability","volume":"35","author":"Schiller","year":"2008","journal-title":"Nucl. Med. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.nucmedbio.2010.05.004","article-title":"Comparison of the stability of Y-90-, Lu-177-and Ga-68-labeled human serum albumin microspheres (DOTA-HSAM)","volume":"37","author":"Wunderlich","year":"2010","journal-title":"Nucl. Med. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s00259-004-1702-y","article-title":"Radiolabelling DOTA-peptides with 68Ga","volume":"32","author":"Breeman","year":"2005","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/8\/1140\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T04:10:20Z","timestamp":1786335020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/8\/1140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ph19081140"],"URL":"https:\/\/doi.org\/10.3390\/ph19081140","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]}}}